Vontobel Holding’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $424K | Buy |
+9,830
| New | +$424K | ﹤0.01% | 836 |
|
|
2024
Q2 | – | Sell |
-30,216
| Closed | -$934K | – | 1080 |
|
|
2024
Q1 | $934K | Sell |
30,216
-595
| -2% | -$18.4K | 0.01% | 605 |
|
|
2023
Q4 | $1.24M | Sell |
30,811
-35,546
| -54% | -$1.43M | 0.01% | 540 |
|
|
2023
Q3 | $1.75M | Sell |
66,357
-1,202
| -2% | -$31.7K | 0.02% | 455 |
|
|
2023
Q2 | $1.16M | Sell |
67,559
-25,161
| -27% | -$433K | 0.01% | 561 |
|
|
2023
Q1 | $1.54M | Sell |
92,720
-12,858
| -12% | -$213K | 0.01% | 481 |
|
|
2022
Q4 | $805K | Buy |
+105,578
| New | +$805K | 0.01% | 630 |
|